AirSculpt Technologies, Inc. Common Stock
AIRSAirSculpt Technologies, Inc. (AIRS) is a medical technology company specializing in minimally invasive body contouring procedures. It develops and offers innovative fat removal and body sculpting solutions through its proprietary AirSculpt platform, aiming to provide safer, more comfortable, and more effective alternatives to traditional liposuction.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 14, 2022 | $0.41 | 2022-08-25 | 2022-08-26 |
Dividends Summary
- Consistent Payer: AirSculpt Technologies, Inc. Common Stock has rewarded shareholders with 1 dividend payments over the past 0 years.
- Total Returned Value: Investors who held AIRS shares during this period received a total of $0.41 per share in dividend income.
- Latest Payout: The most recent dividend of $0.41/share was paid 1403 days ago, on September 14, 2022.
Company News
AirSculpt Technologies appointed Mike Doyle as Non-Executive Chairman of its Board of Directors. Doyle brings over 30 years of leadership experience in multi-center healthcare and has previously led Surgery Partners and founded MD Healthcare Partners.
AirSculpt Technologies reported Q2 2025 financial results with declining case volume and revenue, but narrowed year-over-year revenue decline and reduced net loss. The company is piloting new offerings and remains confident in its growth strategy.
AirSculpt Technologies, Inc. announced the voluntary prepayment of $10 million of its outstanding term loan debt using cash on hand, following the successful completion of its offering of 3,634,000 shares of common stock, which generated net proceeds of approximately $13.8 million.
AirSculpt Technologies, a provider of body contouring procedures, reported its Q1 2025 results. The company saw a decline in case volume and revenue compared to the prior year, leading to a net loss. However, the company expects sequential improvement in revenue as it focuses on increasing lead generation and consultations.
AirSculpt Technologies, a provider of body contouring procedures, reported a decline in revenue and case volume for the fourth quarter and full year 2024. The company is focused on stabilizing same-center sales performance and implementing cost reduction measures.
